Abstract:ABSTRACT Cystic fibrosis (CF), an inherited genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator gene, results in sticky and thick mucosal fluids. This environment facilitates the colonization of various microorganisms, some of which can cause acute and chronic lung infections, while others may positively impact the disease. Rothia mucilaginosa , an oral commensal, is relatively abundant in the lungs of CF patients. Recent studies have unveiled its anti-inflammatory properties using in vitro three-dimensional lung epithelial cell cultures and in vivo mouse models relevant to chronic lung diseases. Apart from this, R. mucilaginosa has been associated with severe infections. However, its metabolic capabilities and genotype-phenotype relationships remain largely unknown. To gain insights into its cellular metabolism and genetic content, we developed the first manually curated genome-scale metabolic model, i RM23NL. Through growth kinetics and high-throughput phenotypic microarray testings, we defined its complete catabolic phenome. Subsequently, we assessed the model’s effectiveness in accurately predicting growth behaviors and utilizing multiple substrates. We used constraint-based modeling techniques to formulate novel hypotheses that could expedite the development of antimicrobial strategies. More specifically, we detected putative essential genes and assessed their effect on metabolism under varying nutritional conditions. These predictions could offer novel potential antimicrobial targets without laborious large-scale screening of knockouts and mutant transposon libraries. Overall, i RM23NL demonstrates a solid capability to predict cellular phenotypes and holds immense potential as a valuable resource for accurate predictions in advancing antimicrobial therapies. Moreover, it can guide metabolic engineering to tailor R. mucilaginosa ’s metabolism for desired performance. IMPORTANCE Cystic fibrosis (CF) is a genetic disorder characterized by thick mucosal secretions, leading to chronic lung infections. Rothia mucilaginosa is a common bacterium found in various parts of the human body, acting as a normal part of the flora. In people with weakened immune systems, it can become an opportunistic pathogen, while it is prevalent and active in CF airways. Recent studies have highlighted its anti-inflammatory properties in the lower pulmonary system, indicating the intricate relationship between microbes and human health. Herein, we have developed the first manually curated metabolic model of R. mucilaginosa . Our study examined the previously unknown relationships between the bacterium’s genotype and phenotype and identified essential genes that impact the metabolism under various conditions. With this, we opt for paving the way for developing new strategies in antimicrobial therapy and metabolic engineering, leading to enhanced therapeutic outcomes in cystic fibrosis and related conditions.

Exploring aggregation genes in a chronic infection model

Flagellar motility and the mucus environment influence aggregation mediated antibiotic tolerance of in chronic lung infection

Autoaggregation in is driven by the Pel polysaccharide

Candida auris undergoes adhesin-dependent and -independent cellular aggregation

Mechanisms of microbial co-aggregation in mixed anaerobic cultures

Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients

Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa

Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes

Methanogenic partner influences cell aggregation and signalling of Syntrophobacterium fumaroxidans

Unravelling a diversity of cellular structures and aggregation dynamics during the early development of Myxococcus xanthus

Modeling Cystic Fibrosis Chronic Infection Using Engineered Mucus-like Hydrogels

A chronic mouse lung infection modeling the pathophysiology and inflammation of human cystic fibrosis

The Involvement of the Low-Oxygen-activated Locus of Burkholderia Cenocepacia in Adaptation During Cystic Fibrosis Infection

Growing a cystic fibrosis-relevant polymicrobial biofilm to probe community phenotypes

A Polymicrobial Perspective of Pulmonary Infections Exposes an Enigmatic Pathogen in Cystic Fibrosis Patients

Loss of O-specific antigen shapes population microbiogeography in murine preclinical pulmonary infection model

Adaptive Interactions of Achromobacter spp. with Pseudomonas aeruginosa in Cystic Fibrosis Chronic Lung Co-Infection

Analysis of genetic requirements and nutrient availability for growth in cystic fibrosis sputum

Achromobacter spp. Adaptation in Cystic Fibrosis Infection and Candidate Biomarkers of Antimicrobial Resistance

Genome-scale model of Rothia mucilaginosa predicts gene essentialities and reveals metabolic capabilities

In Vivo Proteome of Pseudomonas Aeruginosa in Airways of Cystic Fibrosis Patients